XJPX
4928
Market cap963mUSD
Oct 09, Last price
4,525.00JPY
1D
1.57%
1Q
-0.11%
Jan 2017
23.63%
IPO
377.82%
Name
Noevir Holdings Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Noevir Holdings Co., Ltd. is a diversified Japanese conglomerate involved in the creation, production, and distribution of cosmetics, pharmaceuticals, and health food items. Its operations span a wide international footprint, including key markets such as Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada, and Russia. The company's Cosmetics division focuses on developing and manufacturing skincare lines, featuring popular brands like Noevir and Nameraka Honpo. It also offers NOV hypoallergenic products and provides contract manufacturing services for cosmetic and quasi-drug formulations. Within its Pharmaceutical & Health Food segment, Noevir produces items such as Nanten Nodo Ame cough drops and functional beverages like Min Min Da Ha. This division also supplies a range of over-the-counter medications, including cold remedies, eye drops, and digestive aids, alongside various nutritional supplements. The "Other" segment broadens the company's scope through the sale and leasing of apparel and aircraft. Furthermore, the company is involved in manufacturing and selling toiletries, procuring and distributing makeup products and containers, and conducting market research. Its extensive aviation services encompass air transport, charter flight operations, ground handling, hanger rentals, and aircraft flight training, in addition to undertaking other aviation-related tasks. Noevir distributes its diverse product portfolio through multiple channels, including pharmacies, specialized retail outlets, general merchandise stores, supermarkets, e-commerce platforms, convenience stores, and a network of approximately 2,000 Noevir beauty studios and proprietary retail locations. Established in Tokyo, Japan, in 1964, Noevir Holdings Co., Ltd. maintains its headquarters there.
Key people
Akihiro Keyari
President & CEO of Subsidiary, Director · since 2025
Kouzou Matsushita
President & CEO of Subsidiary, Director · since 2025
Takeshi Okura
Managing Director · since 2025
Kazuya Ayukawa
Executive Officer · since 2021
Mitsuyoshi Hanyu
Executive Officer · since 2024
Makoto Hashimoto
Executive Officer · since 2016
Tatsuyuki Tanaka
Executive Officer · since 2022
Takashi Okura
President, Chief Executive Officer, Representative Director · since 2011
Hiroshi Okura
Chairman of the Board, Representative Director · since 2011
Ikkou Yoshida
Vice President, Representative Director · since 2025
Independent Director · since 2018
Mari Ishimitsu
Independent Director · since 2021
Emi Kanagasaki
Independent Director · since 2023
Independent Director · since 2017
Haruhi Kuroda
Independent Director · since 2021
Mari Tomita
Independent Director · since 2023
Independent Director · since 2021
IPO date
Mar 22, 2011
Employees
1,398
Domiciled in
JP
Incorporated in
JP
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||